Bruker Corp (BRKRP) bonds
BRKRPNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31Also trades as BRKR
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/30428% above fair value
$442.19−17.24 (-3.75%)
Close on Nov 12, 2026Market cap $9.36BP/E –Yield –
Debt
Borrowings on the balance sheet, Sep 30, 2026
Total debt
$1.71B
$10.40M due within a year
Net debt
$1.59B
After $119.70M of cash
Implied interest rate
3.04%
FY2025 interest ÷ average debt
Interest coverage
1.1×
FY2025 operating income ÷ interest
Total debt by fiscal year
Long-term plus current debt, USD
When the debt comes due
Principal repayments of long-term debt by fiscal year, as scheduled at Dec 31, 2025
From the debt maturity table in the annual report (filing). “Later” is everything due after year five.
Notes and loans outstanding
As tagged in Bruker's 10-Q for the period ended Jun 30, 2026
| Issue | Matures | Carrying value |
|---|---|---|
| 2019 Term Loan Agreement With Ballon Payment Due December 2026 | Dec 31, 2026 | $0 |
| CHF loan due March 2027 | Mar 31, 2027 | $0 |
| CHF loan due March 2029 | Mar 31, 2029 | $0 |
| CHF loan due December 11, 2029 | Dec 11, 2029 | $367.50M |
| CHF loan due 2029 | 2029 | $0 |
| CHF loan due March 2031 | Mar 31, 2031 | $185.20M |
| CHF loan due December 8, 2031 | Dec 8, 2031 | $371.20M |
| EUR loan due December 8, 2031 | Dec 8, 2031 | $171.30M |
| CHF loan due 2031 | 2031 | $187.30M |
| CHF loan due April 15, 2034 | Apr 15, 2034 | $61.90M |
| CHF loan due April 15, 2036 | Apr 15, 2036 | $242.60M |
| CHF loan due April 15, 2039 | Apr 15, 2039 | $228.90M |
| 2024 Revolving Credit Agreement | – | $170.00M |
| Finance lease obligations | – | $18.10M |
| Other loans | – | $10.00M |
Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.
Credit facilities
Revolving credit lines and other committed borrowing capacity
| Facility | Size | Available |
|---|---|---|
| Amended and Restated Credit Agreement | $900.00M | $729.00M |
| Bank guarantees and working capital line | $197.60M | – |
See a number that looks wrong?